What happened
Ibotta, Inc. (NYSE: IBTA) said Bryan Leach, its CEO and president, sold 49,899 shares on 2026-10-21 under a Rule 10b5-1 plan. The Form 4 also says he is a director and 10% owner.
The shares sold at $48.43 to $50.04 per share, for about $2.47 million. The range was $1.61 per share wide. The filing also says the shares came from stock options exercised the same day.
Leach exercised 21,407 options at $5.35 and 15,346 at $12.75, then sold shares in multiple trades. The options were fully vested and exercisable, according to the filing. The form also shows the Elysian 2024 GST Trust and the Orion 2024 GST Trust converting 6,573 Class B shares each into Class A stock.
After the sales, the filing shows 823,886 direct shares beneficially owned, 34,654 option shares remaining, and indirect trust-linked holdings. Leach signed the form on 2026-10-23.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares sold | 49,899 shares | SEC Form 4 | |
| Sale price range | $48.43 to $50.04 per share | SEC Form 4 | |
| Total sale value | about $2.47 million | SEC Form 4 | |
| Direct shares beneficially owned after the direct-sale rows | 823,886 shares | SEC Form 4 | |
| Option shares remaining | 34,654 shares | SEC Form 4 |
Read more: Ibotta (IBTA) stock analysis and investment case
Why it matters
OptimistFi's case is that Ibotta needs demand to reaccelerate without losing economics. This filing is mixed for that view. It shows a large insider sale, but the trade was preplanned and linked to same-day exercises.
The Rule 10b5-1 plan is the main caveat. Because Leach set it up on March 5, 2026, the timing tells investors less than a spontaneous sale would.
The narrow $1.61 price spread also limits the signal. The form shows Leach still held direct and derivative interests after the sale. For investors, the bigger question is whether Ibotta can keep growing without more insider selling.
The next earnings report will matter more for that demand question than this filing does.
Stock perps: every US stock that trades as a perpetual future, by leverage, live
What's next
The next quarterly report is the next scheduled test. A stronger update would show demand improving without more insider liquidity. A weaker one would keep pressure on the operating thesis.
Until then, this filing mainly clarifies the size and structure of the trade, plus the fact that it was made under a Rule 10b5-1 plan.
More from OptimistFi
- IBTA stock: the Ibotta thesis, its status and the next test to watch
- Stock research on every company OptimistFi covers
From OptimistFi Perps
- Perps news: leveraged stocks, gold, FX and crypto on-chain
- Prop firms that fund crypto and stock perps traders: rules, prices and payouts
- Top perps movers today: stocks, commodities, FX and indices
- Open interest live: crypto and stock perps by exchange
- All perp markets: price, open interest and funding by venue
- Futures calculator: liquidation price, PnL and fees by exchange
Sources
- SEC Form 4 — Bryan Leach insider transaction filing for Ibotta, Inc., filed 2026-10-23.
Read the full OptimistFi thesis on Ibotta, Inc.: https://optimistfi.com/stocks/IBTA
See what would break the Ibotta, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Ibotta, Inc. investment case, its status and the next test to watch live on the Ibotta, Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
